SOLCERA Trademark

Trademark Overview

On Friday, September 28, 2018, a trademark application was filed for SOLCERA with the United States Patent and Trademark Office. The USPTO has given the SOLCERA trademark a serial number of 79245992. The federal status of this trademark filing is REGISTERED as of Tuesday, February 11, 2020. This trademark is owned by INFECTOPHARM Arzneimittel und Consilium GmbH. The SOLCERA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, dermatological products, excluding all pharmaceutical preparation for the treatment of blood diseases and disorders
solcera

General Information

Serial Number79245992
Word MarkSOLCERA
Filing DateFriday, September 28, 2018
Status700 - REGISTERED
Status DateTuesday, February 11, 2020
Registration Number5980145
Registration DateTuesday, February 11, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 26, 2019

Trademark Statements

Goods and ServicesPharmaceutical products, namely, dermatological products, excluding all pharmaceutical preparation for the treatment of blood diseases and disorders
Translation of Words in MarkThe wording "SOLCERA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 26, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameINFECTOPHARM Arzneimittel und Consilium GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressDE
Party NameINFECTOPHARM Arzneimittel und Consilium GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressDE
Party NameINFECTOPHARM Arzneimittel und Consilium GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Trademark Events

Event DateEvent Description
Thursday, November 22, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, November 26, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 30, 2018APPLICATION FILING RECEIPT MAILED
Wednesday, January 9, 2019ASSIGNED TO EXAMINER
Monday, January 14, 2019NON-FINAL ACTION WRITTEN
Tuesday, January 15, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, January 26, 2019REFUSAL PROCESSED BY MPU
Saturday, January 26, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, February 16, 2019REFUSAL PROCESSED BY IB
Friday, April 26, 2019LIMITATION OF GOODS RECEIVED FROM IB
Friday, May 3, 2019LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Monday, May 6, 2019ATTORNEY REVIEW COMPLETED
Monday, August 26, 2019ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, August 26, 2019ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, October 14, 2019TEAS PETITION TO REVIVE RECEIVED
Monday, October 14, 2019PETITION TO REVIVE-GRANTED
Monday, October 14, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 15, 2019NOTICE OF REVIVAL - E-MAILED
Thursday, October 17, 2019ASSIGNED TO LIE
Thursday, October 17, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 17, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 21, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 6, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 26, 2019PUBLISHED FOR OPPOSITION
Tuesday, November 26, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 11, 2020REGISTERED-PRINCIPAL REGISTER
Monday, May 11, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, May 27, 2020GENERIC MADRID TRANSACTION CREATED
Tuesday, February 11, 2025COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, August 14, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, May 27, 2020GENERIC MADRID TRANSACTION SENT TO IB

Related Keywords

solcera pharmaceutical products blood disorders treatment diseases excluding namely dermatological preparation